ResearcherZhejiang Chinese Medical UniversityNo recent work listed
Yifan Qian
Matched on ORCID iD 0009-0008-2021-9372; OpenAlex author ID A5103152561. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2019: 2 papers · 2020: none · 2021: 1 paper
Papers 3
- Valtrate as a novel therapeutic agent exhibits potent anti-pancreatic cancer activity by inhibiting Stat3 signaling. Co-author DOI 10.1016/j.phymed.2021.153537↗
- Coix Seed Extract Enhances the Anti-Pancreatic Cancer Efficacy of Gemcitabine through Regulating ABCB1- and ABCG2-Mediated Drug Efflux: A Bioluminescent Pharma… Co-author DOI 10.3390/ijms20215250↗
- UPLC‑MS/MS‑based metabolomic characterization and comparison of pancreatic adenocarcinoma tissues using formalin‑fixed, paraffin‑embedded and optimal cutting t… Co-author DOI 10.3892/ijo.2019.4898↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Mancang Gu · 3 shared papers, 2019–2021 · strength 0.32
- Paper Valtrate as a novel therapeutic agent exhibits potent anti-pancreatic cancer activity by inhibiting Stat3 signaling. DOI 10.1016/j.phymed.2021.153537↗
- Paper Coix Seed Extract Enhances the Anti-Pancreatic Cancer Efficacy of Gemcitabine through Regulating ABCB1- and ABCG2-Media… DOI 10.3390/ijms20215250↗
- Paper UPLC‑MS/MS‑based metabolomic characterization and comparison of pancreatic adenocarcinoma tissues using formalin‑fixed,… DOI 10.3892/ijo.2019.4898↗
- Di Feng · 2 shared papers, 2019–2021 · strength 0.21
- Paper Valtrate as a novel therapeutic agent exhibits potent anti-pancreatic cancer activity by inhibiting Stat3 signaling. DOI 10.1016/j.phymed.2021.153537↗
- Paper UPLC‑MS/MS‑based metabolomic characterization and comparison of pancreatic adenocarcinoma tissues using formalin‑fixed,… DOI 10.3892/ijo.2019.4898↗
- Liping Chen · 1 shared paper, 2021 · strength 0.12
- Yafang Qian · 1 shared paper, 2021 · strength 0.12
- Li Liu · 1 shared paper, 2019 · strength 0.09
- Yan Xia Shi · 1 shared paper, 2019 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.